Inflammation, Depression Severity, and Response to Ketamine in Treatment-Resistant Depressed Patients: Sex Differences

被引：0
|
作者：
Kruse, Jennifer [1 ]
Hellemann, Gerhard [1 ]
Olmstead, Richard [1 ]
Jiang, Janina [1 ]
Congdon, Eliza [1 ]
Espinoza, Randall [1 ]
Narr, Katherine [1 ]
Irwin, Michael [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Inflammation; Depression; Ketamine; Sex Differences;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
M81
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [21] Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
    Kwasny, Aleksander
    Cubala, Wieslaw Jerzy
    Wlodarczyk, Adam
    Pastuszak, Krzysztof
    PHARMACOLOGICAL REPORTS, 2024, 76 (06) : 1325 - 1332
  • [22] Sex differences in response to olanzapine in treatment-resistant schizophrenia
    Conley, RR
    Kelly, DL
    Feldman, SM
    Tamminga, CA
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 275 - 275
  • [23] Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression
    Moderie, Christophe
    Nunez, Nicolas
    Fielding, Allan
    Comai, Stefano
    Gobbi, Gabriella
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (06): : 479 - 488
  • [24] The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine
    Naughton, M.
    Allen, A. P.
    Clarke, G.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S401 - S401
  • [25] Neural Correlates of Treatment Response to Intravenous Ketamine in Adolescents With Treatment-Resistant Depression
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Amatya, Palistha
    Thai, Michelle
    Schreiner, Melinda Westlund
    Roback, Mark
    Albott, Sophia
    Ren, Yanan
    Eberly, Lynn
    Lim, Kelvin
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S179 - S180
  • [26] Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage
    Scheele, Dirk
    Zimbal, Sophia
    Feinstein, Justin S.
    Delis, Achilles
    Neumann, Claudia
    Mielacher, Clemens
    Philipsen, Alexandra
    Hurlemann, Rene
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (12): : 982 - 986
  • [27] Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
    Del Sant, L. C.
    Magalhaes, E.
    Lucchese, A. C.
    Palhares Alves, H. N.
    Sarin, L. M.
    Del Porto, J. A.
    Tavares de lacerda, A. L.
    EUROPEAN PSYCHIATRY, 2017, 41 : S525 - S526
  • [28] A systematic review of ketamine for treatment-resistant depression
    Patel, Reshmee
    Loh, Feng-Hua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 132 - 132
  • [29] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
  • [30] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
12345